Potentials of organic tellurium-containing compound AS101 to overcome carbapenemase-producing Escherichia coli

CONCLUSION: The in vitro activities, mechanisms, and in vivo study of AS101 against CPEC were unveiled. Our finding provided further evidence for the antibiotic development of AS101.PMID:37516546 | DOI:10.1016/j.jmii.2023.07.002
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Source Type: research